Brookfield Corp’s Bio-Techne TECH Stock Holding History

Brookfield Corp’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-89,999	Closed	-$7.35M	–	483
2023 Q2	$7.35M	Buy	+89,999	New	+$7.23M	0.03%	201
2021 Q2	–	Sell	-11,632	Closed	-$1.11M	–	636
2021 Q1	$1.11M	Buy	+11,632	New	+$1.06M	0.01%	354

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brookfield Corp's TECH Position: Q3 2023 in Review

Brookfield Corp sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 89,999 shares — an estimated $7.35M sold.

Brookfield Corp first reported a position in TECH in Q1 2021 and held it in 2 quarters. The position peaked at $7.35M in Q2 2023. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

Brookfield Corp reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
Brookfield Corp sold 89,999 Bio-Techne shares in Q3 2023, an estimated $7.35M.
Brookfield Corp first reported a position in Bio-Techne in Q1 2021 and held it in 2 quarters.
Brookfield Corp's Bio-Techne position peaked at $7.35M in Q2 2023.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.